Human immunodeficiency virus reverse transcriptase. General properties and its interactions with nucleoside...

Area of Science:

• Biochemistry
• Virology
• Molecular Biology

Background:

• Human immunodeficiency virus (HIV) reverse transcriptase is a key enzyme for viral replication.
• Understanding its activity and inhibition is crucial for developing effective antiviral therapies.
• Comparison with other reverse transcriptases, like human gamma-polymerase-associated reverse transcriptase, aids in selective drug development.

Purpose of the Study:

• To determine optimal reaction assay conditions for human immunodeficiency virus (HIV) reverse transcriptase.
• To investigate the template specificity of HIV reverse transcriptase in comparison to other related enzymes.
• To evaluate the inhibitory effects of various nucleoside analog triphosphates on HIV reverse transcriptase and identify potential drug candidates.

Main Methods:

• Affinity purification of human immunodeficiency virus (HIV) reverse transcriptase.
• Enzyme kinetics assays to determine optimal conditions (MgCl2, KCl concentrations).
• Comparative analysis of enzyme activity and inhibition by nucleoside analogs against HIV and human gamma-reverse transcriptase.

Main Results:

• Optimal incorporation of dTMP by HIV reverse transcriptase occurred at 6 mM MgCl2 and 80 mM KCl.
• HIV reverse transcriptase exhibited distinct template specificity compared to human gamma-polymerase-associated and avian virus reverse transcriptases.
• Several nucleoside analog triphosphates preferentially inhibited HIV reverse transcriptase, with varying effectiveness (3'-fluoro > 3'-amino > 2',3'-dideoxy > 3'-azido).
• Ki values for thymidine triphosphate analogs against HIV reverse transcriptase ranged from 5 to 13 nM.

Conclusions:

• Established optimal conditions for studying HIV reverse transcriptase activity.
• Demonstrated significant differences in template specificity between HIV reverse transcriptase and other related enzymes.
• Identified specific nucleoside analogs with potent inhibitory activity against HIV reverse transcriptase, highlighting their potential for therapeutic development.
• Provided structure-activity relationship data for nucleoside analogs, aiding in the design of novel HIV inhibitors.